The FurtherCardiovascular Outcomes Research With PCSK9 monoclonal antibody (FOURIER) trialinvestigated patients with stable atherosclerotic cardiovascular disease and aprevious myocardial infarction (MI). The gene discussed is PCSK9; the disease is myocardial infarction.